Alps Group Inc (NasdaqGM: ALPS)
Health Care · Biotechnology · MY
$0.31
-1.62% today · -97.4% 1Y
Alps Group Inc (NasdaqGM: ALPS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $53.25M and employs 2 people.
Over the last twelve months the share price has lost 97.4%, trading between 0.38 and 15.00.
Tweenvest scores Alps Group Inc across four factors: quality 32/100, value 55/100. Its strongest factor is value.
ALPS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.25M
- Revenue (TTM)
- $3.74M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- -0.11
- 52-week high
- $15.00
- 52-week low
- $0.38
- Avg volume (3M)
- —
- Shares outstanding
- 166.40M
- Employees
- 2
- Next earnings
- —
About Alps Group Inc
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
- ISIN
- KYG0231P1081
- Listed since
- Oct 31, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.